Dr. Scott M. Rocklage is a highly respected American researcher and accomplished scientist. It is fast approaching the forty-year anniversary since Dr. Scott M. Rocklage started working in the healthcare industry in various capacities. Surprisingly, the charismatic business leader doesn’t show any signs of either slowing down or stopping his decorated career. As it stands, he’s remained as one of the senior partners at the V.C firm, 5AM Ventures. There’s no feeling as surreal and exhilarating like the one drug researchers get when their therapies get the approval of the FDA.
Education & Research Work
Scott is a Ph.D. holder from MIT Medical School. For his undergraduate, Dr. Scott Rocklage attended the prestigious UCLA-Berkeley. has witnessed three new drugs, he and his team developed, get added to the U.S approved drugs index list. The drugs go by the following generic names, Omniscan, Cubicin and Teslascan. What’s more, it’s no secret that the scientist has a couple more drugs still in the approval process waiting for a green light from the FDA.
In the four decades of service to the research and development niche of the medical industry, Dr. Rocklage has been privileged to work with the who’s who list of the big biopharmaceutical firms. He used to work as a CEO and the President of Nycomed Salutar Inc., and Cubist pharmaceuticals. The physician quit his post as a top board member at Novira after it got taken over by the mega-corporation Johnson & Johnson. Additionally, Scott used to head the boards of several publicly traded stock companies namely Epirus, Cidar, Pulamtix and Relypsa Inc and read full article.
30 Patents to His Name
The wise entrepreneur-cum-physician currently resides at his home in Boston, MA with family. Speaking in a recent interview with Ideamensch, the drug developer explained why his company bears the title, ‘5AM Venture’. His response was that the core goal of 5AM Venture is to get there early before the rest awake. In other words, with 5AM Venture holding your back, you’ll build a robust company faster and earlier than your competitors. Very few scientists alive can claim to have successfully filed and received patents for over 30 new discoveries but Dr. Scott Rocklage can. He’s written extensively on a myriad of topics all along the drug development and trials spectrum and if you are interested, you can find his peer-to-peer reviews journals, articles and other scholarly publications online and learn more about Scott.